178 related articles for article (PubMed ID: 27374087)
1. Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells.
Duru N; Gernapudi R; Lo PK; Yao Y; Wolfson B; Zhang Y; Zhou Q
Oncotarget; 2016 Jul; 7(30):47511-47525. PubMed ID: 27374087
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions.
Li Q; Eades G; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2014 Jan; 289(3):1303-12. PubMed ID: 24297178
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
5. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Park SY; Lee HE; Li H; Shipitsin M; Gelman R; Polyak K
Clin Cancer Res; 2010 Feb; 16(3):876-87. PubMed ID: 20103682
[TBL] [Abstract][Full Text] [Related]
7. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
Li Q; Yao Y; Eades G; Liu Z; Zhang Y; Zhou Q
Oncogene; 2014 May; 33(20):2589-600. PubMed ID: 23752191
[TBL] [Abstract][Full Text] [Related]
11. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
Han SA; Jang JH; Won KY; Lim SJ; Song JY
Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
Oliveira-Costa JP; Zanetti JS; Silveira GG; Soave DF; Oliveira LR; Zorgetto VA; Soares FA; Zucoloto S; Ribeiro-Silva A
Diagn Pathol; 2011 Aug; 6():73. PubMed ID: 21824412
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
[TBL] [Abstract][Full Text] [Related]
16. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
Zhu J; He J; Liu Y; Simeone DM; Lubman DM
J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
[TBL] [Abstract][Full Text] [Related]
17. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer.
Arima Y; Hayashi N; Hayashi H; Sasaki M; Kai K; Sugihara E; Abe E; Yoshida A; Mikami S; Nakamura S; Saya H
Int J Cancer; 2012 Jun; 130(11):2568-79. PubMed ID: 21717460
[TBL] [Abstract][Full Text] [Related]
18. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.
Keller PJ; Lin AF; Arendt LM; Klebba I; Jones AD; Rudnick JA; DiMeo TA; Gilmore H; Jefferson DM; Graham RA; Naber SP; Schnitt S; Kuperwasser C
Breast Cancer Res; 2010; 12(5):R87. PubMed ID: 20964822
[TBL] [Abstract][Full Text] [Related]
19. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
[TBL] [Abstract][Full Text] [Related]
20. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.
Tiezzi DG; Valejo FA; Marana HR; Carrara HH; Benevides L; Antonio HM; Sicchieri RD; Milanezi CM; Silva JS; de Andrade JM
Med Oncol; 2012 Sep; 29(3):1479-85. PubMed ID: 21713550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
